On the public citation graph

Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer’s Disease

https://doi.org/10.1007/s11064-014-1304-4
0 signed · 135 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneurol.2009.15openalex-snapshot
Epilepsy and Cognitive Impairments in Alzheimer Disease
inferredcites →https://doi.org/10.1002/(sici)1520-6394(1998)7:4<166::aid-da4>3.0.co;2-8openalex-snapshot
Prevalence and correlates of anxiety in Alzheimer's disease
inferredcites →https://doi.org/10.1002/1099-1166(200112)16:1+<::aid-gps568>3.0.co;2-mopenalex-snapshot
Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis
inferredcites →https://doi.org/10.1002/14651858.cd001191openalex-snapshot
Rivastigmine for Alzheimer's disease
inferredcites →https://doi.org/10.1002/14651858.cd001191.pub4openalex-snapshot
Rivastigmine for Alzheimer's disease
inferredcites →https://doi.org/10.1002/14651858.cd003154.pub3openalex-snapshot
Memantine for dementia
inferredcites →https://doi.org/10.1002/14651858.cd003154.pub5openalex-snapshot
Memantine for dementia
inferredcites →https://doi.org/10.1006/exnr.1997.6591openalex-snapshot
Immunohistochemical Study of GABAAReceptor β2/3 Subunits in the Hippocampal Formation of Aged Brains with Alzheimer-Related Neuropathologic Changes
inferredcites →https://doi.org/10.1007/bf03351476openalex-snapshot
Natural history of Alzheimer’s disease
inferredcites →https://doi.org/10.1007/s10059-011-0075-xopenalex-snapshot
Effects of Amyloid-β Peptides on Voltage-Gated L-Type CaV1.2 and CaV1.3 Ca2+ Channels
inferredcites →https://doi.org/10.1007/s40263-013-0074-xopenalex-snapshot
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
inferredcites →https://doi.org/10.1016/j.bbadis.2011.08.013openalex-snapshot
Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine
inferredcites →https://doi.org/10.1016/j.expneurol.2007.10.008openalex-snapshot
Amyloid beta peptides and glutamatergic synaptic dysregulation
inferredcites →https://doi.org/10.1016/j.neuron.2007.07.025openalex-snapshot
Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease
inferredcites →https://doi.org/10.1016/j.neuron.2013.07.004openalex-snapshot
Counting Gephyrins, One at a Time: A Nanoscale View on the Inhibitory Postsynapse
inferredcites →https://doi.org/10.1016/j.neuropharm.2010.10.020openalex-snapshot
The rise of a new GABA pharmacology
inferredcites →https://doi.org/10.1016/j.neuroscience.2006.08.054openalex-snapshot
Metallothionein-I and -III expression in animal models of Alzheimer disease
inferredcites →https://doi.org/10.1016/j.neuroscience.2011.04.010openalex-snapshot
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis
inferredcites →https://doi.org/10.1016/j.stem.2009.10.003openalex-snapshot
Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease
inferredcites →https://doi.org/10.1016/s0006-8993(98)00437-5openalex-snapshot
Immunohistochemical study of GABAA receptor α1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes
inferredcites →https://doi.org/10.1016/s0169-328x(97)00347-1openalex-snapshot
GABAA receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology
inferredcites →https://doi.org/10.1016/s0197-4580(01)00342-6openalex-snapshot
Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
inferredcites →https://doi.org/10.1038/aps.2013.7openalex-snapshot
Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease
inferredcites →https://doi.org/10.1038/nm0706-780openalex-snapshot
Alzheimer disease: progress or profit?
inferredcites →https://doi.org/10.1038/nprot.2013.155openalex-snapshot
Object recognition test in mice
inferredcites →https://doi.org/10.1038/nrn1556openalex-snapshot
Receptor trafficking and synaptic plasticity
inferredcites →https://doi.org/10.1038/nrn3670openalex-snapshot
Gephyrin: a master regulator of neuronal function?
inferredcites →https://doi.org/10.1042/bj20120653openalex-snapshot
Is the Amyloid Hypothesis of Alzheimer's disease therapeutically relevant?
inferredcites →https://doi.org/10.1073/pnas.1204606109openalex-snapshot
Loss of functional GABA A receptors in the Alzheimer diseased brain
inferredcites →https://doi.org/10.1074/jbc.m112.341826openalex-snapshot
Splice-specific Glycine Receptor Binding, Folding, and Phosphorylation of the Scaffolding Protein Gephyrin
inferredcites →https://doi.org/10.1074/jbc.m312946200openalex-snapshot
Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein Precursor
inferredcites →https://doi.org/10.1083/jcb.201104133openalex-snapshot
Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology
inferredcites →https://doi.org/10.1093/gerona/54.7.m348openalex-snapshot
Anxiety in Alzheimer's Disease: Prevalence and Comorbidity
inferredcites →https://doi.org/10.1096/fj.03-0739comopenalex-snapshot
Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders
inferredcites →https://doi.org/10.1097/01.jnen.0000435847.59828.dbopenalex-snapshot
Abnormal Gephyrin Immunoreactivity Associated With Alzheimer Disease Pathologic Changes
inferredcites →https://doi.org/10.1111/j.1460-9568.1993.tb00965.xopenalex-snapshot
Distribution of Gephyrin Transcripts in the Adult and Developing Rat Brain
inferredcites →https://doi.org/10.1111/j.1471-4159.2011.07237.xopenalex-snapshot
Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s disease
inferredcites →https://doi.org/10.1111/j.1530-0277.2007.00563.xopenalex-snapshot
Normal Acute Behavioral Responses to Moderate/High Dose Ethanol in GABAAReceptor α4 Subunit Knockout Mice
inferredcites →https://doi.org/10.1111/j.1530-0277.2007.00564.xopenalex-snapshot
Functional Consequences of GABAAReceptor α4 Subunit Deletion on Synaptic and Extrasynaptic Currents in Mouse Dentate Granule Cells
inferredcites →https://doi.org/10.1111/jnc.12304openalex-snapshot
Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease
inferredcites →https://doi.org/10.1113/jphysiol.1952.sp004735openalex-snapshot
Spontaneous subthreshold activity at motor nerve endings
inferredcites →https://doi.org/10.1113/jphysiol.1984.sp015482openalex-snapshot
Inhibitory post‐synaptic currents in rat hippocampal CA1 neurones.
inferredcites →https://doi.org/10.1113/jphysiol.1990.sp018236openalex-snapshot
Characteristics of miniature inhibitory postsynaptic currents in CA1 pyramidal neurones of rat hippocampus.
inferredcites →https://doi.org/10.1124/jpet.104.067983openalex-snapshot
Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence
inferredcites →https://doi.org/10.1126/science.282.5392.1321openalex-snapshot
Dual Requirement for Gephyrin in Glycine Receptor Clustering and Molybdoenzyme Activity
inferredcites →https://doi.org/10.1136/jnnp.66.2.137openalex-snapshot
The cholinergic hypothesis of Alzheimer's disease: a review of progress
inferredcites →https://doi.org/10.1152/jn.01122.2005openalex-snapshot
Hippocampal Network Hyperactivity After Selective Reduction of Tonic Inhibition in GABAA Receptor α5 Subunit–Deficient Mice
inferredcites →https://doi.org/10.1152/jn.90484.2008openalex-snapshot
Tolerance to Sedative/Hypnotic Actions of GABAergic Drugs Correlates With Tolerance to Potentiation of Extrasynaptic Tonic Currents of Alcohol-Dependent Rats
inferredcites →https://doi.org/10.1152/physrev.2001.81.2.741openalex-snapshot
Alzheimer's Disease: Genes, Proteins, and Therapy
inferredcites →https://doi.org/10.1155/2013/608430openalex-snapshot
Molecular Imaging in Traditional Chinese Medicine Therapy for Neurological Diseases
inferredcites →https://doi.org/10.1176/appi.neuropsych.15.2.180openalex-snapshot
Frequency and Characteristics of Anxiety Among Patients With Alzheimer's Disease and Related Dementias
inferredcites →https://doi.org/10.1177/070674370404900705openalex-snapshot
GABAergic Function in Alzheimer's Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia
inferredcites →https://doi.org/10.1177/089198879400700407openalex-snapshot
Seizures in Alzheimer's Disease: Clinicopathologic Study
inferredcites →https://doi.org/10.1212/01.wnl.0000129697.01779.0aopenalex-snapshot
The importance of neuritic plaques and tangles to the development and evolution of AD
inferredcites →https://doi.org/10.1212/wnl.0000000000000229openalex-snapshot
Spotlight on the March 11 Issue
inferredcites →https://doi.org/10.1212/wnl.0000000000000240openalex-snapshot
Contribution of Alzheimer disease to mortality in the United States
inferredcites →https://doi.org/10.1385/nmm:4:1-2:21openalex-snapshot
Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases
inferredcites →https://doi.org/10.1503/cmaj.130451openalex-snapshot
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1523/jneurosci.19-21-09289.1999openalex-snapshot
Loss of Postsynaptic GABAAReceptor Clustering in Gephyrin-Deficient Mice
inferredcites →https://doi.org/10.1523/jneurosci.2786-07.2007openalex-snapshot
Mechanisms of Reversible GABA A Receptor Plasticity after Ethanol Intoxication
inferredcites →https://doi.org/10.1523/jneurosci.4639-11.2012openalex-snapshot
Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication
inferredcites →https://doi.org/10.1523/jneurosci.5050-07.2008openalex-snapshot
The Clustering of GABAAReceptor Subtypes at Inhibitory Synapses is Facilitated via the Direct Binding of Receptor α2 Subunits to Gephyrin
inferredcites →https://doi.org/10.1590/s1807-59322011001300006openalex-snapshot
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
inferredcites →https://doi.org/10.2174/156720509787602852openalex-snapshot
Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
inferredcites →https://doi.org/10.3233/jad-2008-14305openalex-snapshot
Reduced Expression of the Inhibitory Synapse Scaffolding Protein Gephyrin in Alzheimer's Disease
inferredcites →https://doi.org/10.3389/fncel.2012.00023openalex-snapshot
Gephyrin, the enigmatic organizer at GABAergic synapses
inferredcites →https://doi.org/10.3389/neuro.03.001.2007openalex-snapshot
Effects of N-cadherin disruption on spine morphological dynamics
inferredcites →https://doi.org/10.4088/jcp.12m08099openalex-snapshot
Safety and Efficacy of Methylphenidate for Apathy in Alzheimer’s Disease
inferredcites →https://doi.org/10.4103/0973-7847.120511openalex-snapshot
Cholinesterase inhibitors from botanicals

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3981437openalex-extracted
Triptolide Reduced Alzheimer's Disease-Like Presentation in Mice
inferred← citeshttps://doi.org/10.1002/alz.70122openalex-snapshot
Cerebral proteome adaptations to amyloid angiopathy are prevented by carbonic anhydrase inhibitors
inferred← citeshttps://doi.org/10.1002/fsn3.4547openalex-snapshot
Vine Tea Extract Enhanced the Fermentation of Skimmed Milk by Lacticaseibacillus casei
inferred← citeshttps://doi.org/10.1002/mnfr.202101002openalex-snapshot
Dihydromyricetin Improves Cognitive Impairments in d ‐Galactose‐Induced Aging Mice through Regulating Oxidative Stress and Inhibition of Acetylcholinesterase
inferred← citeshttps://doi.org/10.1002/syn.22261openalex-snapshot
Triptolide injection reduces Alzheimer's disease‐like pathology in mice
inferred← citeshttps://doi.org/10.1007/978-3-319-51639-4_11openalex-snapshot
Neurocognitive Improvement Through Plant Food Bioactives: A Particular Approach to Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-981-95-4751-7_10openalex-snapshot
Photo-Secondary Metabolites as a Potential Therapeutic Gateway for Alzheimer’s Disease Management
inferred← citeshttps://doi.org/10.1007/s00213-017-4761-zopenalex-snapshot
Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation
inferred← citeshttps://doi.org/10.1007/s00418-018-1725-2openalex-snapshot
Gephyrin: a key regulatory protein of inhibitory synapses and beyond
inferred← citeshttps://doi.org/10.1007/s12031-016-0801-0openalex-snapshot
Dihydromyricetin Ameliorates 3NP-induced Behavioral Deficits and Striatal Injury in Rats
inferred← citeshttps://doi.org/10.1007/s12035-015-9627-yopenalex-snapshot
Dihydromyricetin Improves Hypobaric Hypoxia-Induced Memory Impairment via Modulation of SIRT3 Signaling
inferred← citeshttps://doi.org/10.1007/s12035-025-04715-wopenalex-snapshot
Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer’s Disease and Regulation by Natural Plant Products
inferred← citeshttps://doi.org/10.1007/s12640-022-00503-9openalex-snapshot
Dihydromyricetin Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line: Role of GABAA Receptor
inferred← citeshttps://doi.org/10.1016/j.ajpath.2016.05.013openalex-snapshot
Biphasic Alteration of the Inhibitory Synapse Scaffold Protein Gephyrin in Early and Late Stages of an Alzheimer Disease Model
inferred← citeshttps://doi.org/10.1016/j.arr.2020.101192openalex-snapshot
The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.biocel.2022.106273openalex-snapshot
Mechanisms of NLRP3 activation and pathology during neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111428openalex-snapshot
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.ejphar.2019.03.014openalex-snapshot
Dihydromyricetin ameliorates memory impairment induced by acute sleep deprivation
inferred← citeshttps://doi.org/10.1016/j.expneurol.2025.115189openalex-snapshot
Tg-SwDI transgenic mice: A suitable model for Alzheimer's disease and cerebral amyloid angiopathy basic research and preclinical studies
inferred← citeshttps://doi.org/10.1016/j.foodchem.2021.132033openalex-snapshot
Stability profiling and degradation products of dihydromyricetin in Dulbecco's modified eagle's medium
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e18396openalex-snapshot
Discovery of drug lead compounds for Anti-Alzheimer's disease on the basis of synaptic plasticity
inferred← citeshttps://doi.org/10.1016/j.intimp.2016.12.018openalex-snapshot
Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia
inferred← citeshttps://doi.org/10.1016/j.jep.2023.116788openalex-snapshot
A comprehensive review of vine tea: Origin, research on Materia Medica, phytochemistry and pharmacology
inferred← citeshttps://doi.org/10.1016/j.mcn.2021.103624openalex-snapshot
Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-β and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model
inferred← citeshttps://doi.org/10.1016/j.neuint.2021.104958openalex-snapshot
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neuint.2022.105434openalex-snapshot
Social isolation induces succinate dehydrogenase dysfunction in anxious mice
inferred← citeshttps://doi.org/10.1016/j.neulet.2023.137404openalex-snapshot
Dihydromyricetin alleviates hippocampal ferroptosis in type 2 diabetic cognitive impairment rats via inhibiting the JNK-inflammatory factor pathway
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2019.07.036openalex-snapshot
Tuning GABAergic Inhibition: Gephyrin Molecular Organization and Functions
inferred← citeshttps://doi.org/10.1016/j.ynstr.2022.100499openalex-snapshot
Dihydromyricetin ameliorates social isolation-induced anxiety by modulating mitochondrial function, antioxidant enzymes, and BDNF
inferred← citeshttps://doi.org/10.1021/acs.jafc.8b02433openalex-snapshot
Dihydromyricetin Inhibits Lead-Induced Cognitive Impairments and Inflammation by the Adenosine 5′-Monophosphate-Activated Protein Kinase Pathway in Mice
inferred← citeshttps://doi.org/10.1021/acschemneuro.9b00480openalex-snapshot
Inhibitory Effect of a Flavonoid Dihydromyricetin against Aβ40 Amyloidogenesis and Its Associated Cytotoxicity
inferred← citeshttps://doi.org/10.1038/aps.2016.42openalex-snapshot
Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity
inferred← citeshttps://doi.org/10.1038/s41598-022-09814-5openalex-snapshot
Dihydromyricetin improves social isolation-induced cognitive impairments and astrocytic changes in mice
inferred← citeshttps://doi.org/10.1055/a-1206-6757openalex-snapshot
The Effect of Dihydromyricetin, a Natural Flavonoid, on Morphine-induced Conditioned Place Preference and Physical Dependence in Mice
inferred← citeshttps://doi.org/10.1080/01616412.2021.1997010openalex-snapshot
Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex
inferred← citeshttps://doi.org/10.1093/abbs/gmy003openalex-snapshot
Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice
inferred← citeshttps://doi.org/10.1093/cercor/bhw218openalex-snapshot
Prefrontal Cortical GABAergic Dysfunction Contributes to Aberrant UP-State Duration in APP Knockout Mice
inferred← citeshttps://doi.org/10.1093/oxfordhb/9780190669164.013.6openalex-snapshot
GABAA Receptor Physiology and Pharmacology
inferred← citeshttps://doi.org/10.1111/cns.12983openalex-snapshot
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP / PS 1 transgenic mice
inferred← citeshttps://doi.org/10.1155/2017/1053617openalex-snapshot
The Versatile Effects of Dihydromyricetin in Health
inferred← citeshttps://doi.org/10.1155/2020/3472578openalex-snapshot
Metabolomics of the Protective Effect of Ampelopsis grossedentata and Its Major Active Compound Dihydromyricetin on the Liver of High‐Fat Diet Hamster
inferred← citeshttps://doi.org/10.11648/j.cnn.20230704.13openalex-snapshot
The Therapeutic Role of Flavonoids for Alzheimer's Disease
inferred← citeshttps://doi.org/10.1177/1934578x20946250openalex-snapshot
Antialcohol Effects of Dihydromyricetin in Combination With Other Flavonoids
inferred← citeshttps://doi.org/10.1186/s12974-021-02368-9openalex-snapshot
Social isolation induces neuroinflammation and microglia overactivation, while dihydromyricetin prevents and improves them
inferred← citeshttps://doi.org/10.1186/s40035-019-0159-7openalex-snapshot
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
inferred← citeshttps://doi.org/10.1212/wnl.0000000000008981openalex-snapshot
Dietary flavonols and risk of Alzheimer dementia
inferred← citeshttps://doi.org/10.1212/wnl.0000000000201541openalex-snapshot
Association of Dietary Intake of Flavonols With Changes in Global Cognition and Several Cognitive Abilities
inferred← citeshttps://doi.org/10.1242/dmm.049627openalex-snapshot
Molecular inhibition of RAS signalling to target ageing and age-related health
inferred← citeshttps://doi.org/10.12692/ijb/14.5.378-388openalex-snapshot
Dihydromyricetin, a multi-perspective medicinal entity
inferred← citeshttps://doi.org/10.1515/hsz-2021-0153openalex-snapshot
Artemisinin-treatment in pre-symptomatic APP-PS1 mice increases gephyrin phosphorylation at Ser270: a modification regulating postsynaptic GABAAR density
inferred← citeshttps://doi.org/10.1586/14789450.2015.1000869openalex-snapshot
Proteomics: in pursuit of effective traumatic brain injury therapeutics
inferred← citeshttps://doi.org/10.2139/ssrn.4065674openalex-snapshot
Substrate-Selective Positive Allosteric Modulation of Ptprd's Phosphatase by Flavonols
inferred← citeshttps://doi.org/10.2174/1871527322666230718105358openalex-snapshot
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.3233/bpl-200098openalex-snapshot
Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action
inferred← citeshttps://doi.org/10.3233/jad-201549openalex-snapshot
Polyphenol-Peptide Interactions in Mitigation of Alzheimer’s Disease: Role of Biosurface-Induced Aggregation
inferred← citeshttps://doi.org/10.32907/ro-135-4341231342openalex-snapshot
Loneliness and social isolation How can we protect our mental health and cognitive functions?
inferred← citeshttps://doi.org/10.3389/fnagi.2020.601603openalex-snapshot
Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer’s Diseases
inferred← citeshttps://doi.org/10.3389/fphar.2019.01334openalex-snapshot
Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.3389/fphar.2020.01008openalex-snapshot
Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety
inferred← citeshttps://doi.org/10.3389/fphar.2024.1407335openalex-snapshot
Ferroptosis inhibitors: past, present and future
inferred← citeshttps://doi.org/10.3389/fphar.2025.1618623openalex-snapshot
Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders
inferred← citeshttps://doi.org/10.3390/antibiotics12020262openalex-snapshot
Disulfiram—Mitigating Unintended Effects
inferred← citeshttps://doi.org/10.3390/biom10060870openalex-snapshot
Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/genes15010047openalex-snapshot
Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/ijms24054297openalex-snapshot
Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging
inferred← citeshttps://doi.org/10.3390/nu13020342openalex-snapshot
Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.